Bulletin
Investor Alert

Company Close Updates

May 9, 2022, 5:18 p.m. EDT

Regeneron Pharmaceuticals Inc. stock falls Monday, underperforms market

MarketWatch Automation

Shares of Regeneron Pharmaceuticals Inc. (NAS:REGN) slid 3.74% to $599.77 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index (S&P:SPX) falling 3.20% to 3,991.24 and Dow Jones Industrial Average (DOW:DJIA) falling 1.99% to 32,245.70. This was the stock's third consecutive day of losses. Regeneron Pharmaceuticals Inc. closed $147.65 short of its 52-week high ($747.42), which the company achieved on April 8th.

The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson (NYS:JNJ) rose 0.54% to $177.33, Novartis AG ADR (NYS:NVS) fell 2.73% to $83.48, and Amgen Inc. (NAS:AMGN) rose 1.16% to $239.24. Trading volume (818,064) eclipsed its 50-day average volume of 648,090.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Link to MarketWatch's Slice.